FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 53 filers reported holding FENNEC PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $823 | -98.4% | 110 | -98.0% | 0.00% | – |
Q2 2023 | $50,681 | -66.5% | 5,404 | -70.9% | 0.00% | – |
Q1 2023 | $151,099 | -7.2% | 18,590 | +10.3% | 0.00% | – |
Q4 2022 | $162,766 | +1708.5% | 16,848 | +1069.2% | 0.00% | – |
Q1 2021 | $9,000 | -70.0% | 1,441 | -65.2% | 0.00% | – |
Q4 2020 | $30,000 | +400.0% | 4,141 | +302.8% | 0.00% | – |
Q3 2020 | $6,000 | -75.0% | 1,028 | -64.6% | 0.00% | – |
Q2 2020 | $24,000 | +242.9% | 2,900 | +159.4% | 0.00% | – |
Q1 2020 | $7,000 | +16.7% | 1,118 | -14.5% | 0.00% | – |
Q3 2019 | $6,000 | -25.0% | 1,308 | -26.2% | 0.00% | – |
Q2 2019 | $8,000 | -50.0% | 1,773 | -46.5% | 0.00% | – |
Q1 2019 | $16,000 | -15.8% | 3,313 | +8.8% | 0.00% | – |
Q4 2018 | $19,000 | -26.9% | 3,046 | -4.8% | 0.00% | – |
Q3 2018 | $26,000 | +52.9% | 3,199 | +96.5% | 0.00% | – |
Q2 2018 | $17,000 | – | 1,628 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 2,433,230 | $18,128,000 | 8.76% |
Solas Capital Management, LLC | 800,000 | $5,960,000 | 4.55% |
Southpoint Capital Advisors LP | 4,077,214 | $30,375,000 | 0.53% |
683 Capital Management, LLC | 1,110,000 | $8,269,000 | 0.39% |
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 40,000 | $298,000 | 0.26% |
Avoro Capital Advisors LLC | 1,670,000 | $12,442,000 | 0.21% |
Eventide Asset Management | 1,120,000 | $8,344,000 | 0.13% |
Hartford Financial Management Inc. | 38,848 | $289,000 | 0.08% |
Granahan Investment Management | 394,810 | $2,941,000 | 0.07% |
Planned Solutions, Inc. | 800 | $6,000 | 0.01% |